Universe Pharmaceuticals INC Increase (Decrease) in Accrued Investment Income Receivable
Universe Pharmaceuticals INC (UPC) reported Increase (Decrease) in Accrued Investment Income Receivable of $3.09 million for the 6-month period ending 2024-03-31, per its 6-K filed 2024-09-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable · last filed 2024-09-20
| Period end | Increase (Decrease) in Accrued Investment Income Receivable 6 month | Increase (Decrease) in Accrued Investment Income Receivable 12 month | Increase (Decrease) in Accrued Investment Income Receivable 12 month as first filed |
|---|---|---|---|
| 2024-03-31 | $3.09M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | -$38.53K 6-K · filed 2024-09-20 | $38.53K 20-F · filed 2024-01-30 | |
| 2023-03-31 | $166.93K 6-K · filed 2023-08-31 | ||
| 2022-09-30 | -$470.48K 20-F · filed 2024-01-30 | ||
| 2022-03-31 | $696.43K 6-K · filed 2022-08-16 | ||
| 2021-09-30 | $239.55K 20-F · filed 2023-02-10 |